The fully flexible, reconfigurable Intelligent Island Manufacturing System (I²MS) supports high-mix manufacturing, enables ...

Manufacturing SOP creation is breaking down as critical process knowledge remains trapped in training videos and ...

Data indicate that the AutoCell platform could pave the way for CGTs for the first time as first-line therapies.

Autolus Therapeutics is working with Cellares to assess automated CAR T manufacturing to support rising demand for its ...

The Cellares Cell Shuttle platform was the first to receive the FDA’s Advanced Manufacturing Technology (AMT) designation, which offers partners additional touchpoints and priority review mechanisms ...